市场调查报告书
商品编码
1492546
食道支架市场:按类型、材料、应用和最终用户划分 - 全球预测 2024-2030Esophageal Stents Market by Type (Biodegradable Stents, Self-expandable Metal Stents, Self-expandable Plastic Stents), Material (Nitinol, Silicone, Stainless Steel), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年食道支架市场规模为1.504亿美元,预计2024年将达到1.5947亿美元,2030年将达2.301亿美元,复合年增长率为6.26%。
食道支架是一种由金属或塑胶製成的管状装置,用于打开食道狭窄(将食物从喉咙输送到胃的管道)。这些支架主要用于治疗食道狭窄或阻塞,这些狭窄或阻塞通常由癌症、胃食道逆流症 (GERD) 或其他疾病引起。由于食道癌盛行率不断增加、支架技术的进步提高了患者的舒适度和治疗结果,以及与传统手术相比支架置入的微创性,食道支架的使用正在扩大。儘管有这些好处,食道支架可能会导致併发症,例如迁移(支架从其原始位置移动)或因肿瘤生长穿过支架而再次闭塞。此外,患者可能会感到不适和疼痛,尤其是吞嚥时。需要不断改进支架设计来解决这些问题。例如,开发随着时间的推移而溶解的生物分解性支架,减少额外手术的需要,或在支架上涂上药物以对抗肿瘤生长。然而,随着对支架材料和涂层的研究不断深入,以提高与身体的相容性并减少併发症,市场将继续成长。还有可能利用 3D 列印技术的进步,根据患者的个人医疗需求客製化支架。
主要市场统计 | |
---|---|
基准年[2023] | 1.504 亿美元 |
预测年份 [2024] | 1.5947亿美元 |
预测年份 [2030] | 2.301 亿美元 |
复合年增长率(%) | 6.26% |
区域洞察
在美国和加拿大,先进医疗技术的采用率很高,包括使用食道支架来治疗食道癌和良性食道狭窄。该市场得到了成熟的医疗基础设施和有利的报销政策的支持。至于欧洲、中东和非洲地区,欧洲在市场成熟度方面处于领先地位,特别是在德国、法国和英国等国家,医疗费用的上升和食道疾病的流行正在推动市场的发展。中东和非洲正在逐渐迎头赶上,但市场成长因不同程度的医疗保健和财务限製而受到阻碍。亚太地区显示出巨大的成长潜力,特别是中国、日本和印度等国家。医疗保健标准的提高、中阶的壮大和医疗旅游业的扩大推动了这一增长。
FPNV定位矩阵
FPNV 定位矩阵对于评估食道支架市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对食道支架市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前食道支架市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[189 Pages Report] The Esophageal Stents Market size was estimated at USD 150.40 million in 2023 and expected to reach USD 159.47 million in 2024, at a CAGR 6.26% to reach USD 230.10 million by 2030.
Esophageal stents are tubular devices made of metal or plastic that are used to open narrowed areas of the esophagus, the tube that carries food from the throat to the stomach. These stents are primarily used to treat esophageal strictures or blockages, often caused by cancer, gastroesophageal reflux disease (GERD), or other medical conditions. The growing prevalence of esophageal cancer advances in stent technology that improves patient comfort and outcomes and the minimally invasive nature of stent placement compared to traditional surgical procedures have expanded the use of esophageal stents. Despite their benefits, esophageal stents can cause complications, such as migration, where the stent moves from its original position or re-obstruction caused by tumor growth through the stent. Additionally, patients may experience discomfort or pain, particularly when swallowing. Addressing these issues involves continuous improvements in stent design, such as developing biodegradable stents that dissolve over time, reducing the need for additional procedures, or coating stents with drugs to help combat tumor growth. Nevertheless, increasing research into stent materials and coatings that enhance compatibility with the body and reduce complications provides added growth for the market. There is also potential in customizing stents for patients based on personalized medical needs, leveraging advances in 3D printing technology.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 150.40 million |
Estimated Year [2024] | USD 159.47 million |
Forecast Year [2030] | USD 230.10 million |
CAGR (%) | 6.26% |
Regional Insights
In the Americas, U.S., and Canada, there is a high adoption rate of advanced medical technologies, which includes the use of esophageal stents for conditions including esophageal cancer and benign esophageal strictures. The market is supported by well-established healthcare infrastructure and favorable reimbursement policies. Moving to EMEA, Europe leads in terms of market maturity, especially in countries such as Germany, France, and the UK, which are driven by increasing healthcare expenditure and the prevalence of esophageal diseases. The Middle East and Africa are gradually catching up, although the market growth here is tempered by varying levels of healthcare access and economic constraints. The Asia Pacific region showcases significant growth potential, particularly in countries such as China, Japan, and India. This growth is spurred by rising healthcare standards, an increasing middle-class population, and growing medical tourism.
Market Insights
The market dynamics represent an ever-changing landscape of the Esophageal Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Esophageal Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Esophageal Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Olympus Corporation Advances in Gastrointestinal Treatment Through Acquisition of Taewoong Medical
Olympus Corporation finalized its acquisition of Taewoong Medical Co., Ltd., a South Korean firm renowned for its advanced gastrointestinal metallic stents. This strategic move, valued at approximately USD 370 million, integrates Taewoong Medical into Olympus' Therapeutic Solutions Division, enhancing its capabilities in the GI EndoTherapy arena. This acquisition fortifies Olympus's portfolio in providing comprehensive GI solutions and aims to elevate patient care standards globally. [Published On: 2024-01-24]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Esophageal Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Esophageal Stents Market, highlighting leading vendors and their innovative profiles. These include Advin Healthcare Private Limited, Boston Scientific Corporation, Changzhou Health Microport Medical Device Co., LTD., Cook Group Incorporated, ELLA-CS, s.r.o., ENDO-FLEX GmbH. by Medi-Globe Group, Leufen Medical by bess AG., M.I.TECH., Medorah Meditek Pvt. Ltd., Medtronic plc, Merit Medical Systems, Inc., MICRO-TECH (Nanjing) Co., Ltd., Micro-Tech Endoscopy, Mitra Industries Pvt. Ltd., Olympus Corporation, S&G Biotech Inc., TAEWOONG MEDICAL Co., Ltd, and W. L. Gore & Associates, Inc..
Market Segmentation & Coverage